https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Prediction of multiple sclerosis outcomes when switching to ocrelizumab https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46515 Thu 24 Nov 2022 15:50:23 AEDT ]]> Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36736 Thu 02 Jul 2020 16:31:45 AEST ]]> Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48108 Mon 27 Feb 2023 15:18:00 AEDT ]]> Prediction of relapse activity when switching to cladribine for multiple sclerosis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51076 Fri 18 Aug 2023 09:03:23 AEST ]]>